BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Delcath Systems Reports Second Quarter 2023 Results and Provides Business Update

  Delcath Systems, Inc., an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, reported business highlights and financial results for the second quarter ended June 30, 2023.

  August 9, 2023

   · 

  8 min read
• Policy

  Accuray Receives FDA Clearance for VitalHold™ on the Radixact® System; Breast Cancer Treatment Option Will Also Be Available in the EU Market

  Accuray Incorporated announced that the company has received 510 clearance from the U.S. Food and Drug Administration for its VitalHold™* breast package on the Radixact® System.

  August 9, 2023

   · 

  5 min read
• Deals

  Amyris Announces Operational and Financial Restructuring to Advance Strategic Transformation

  Amyris, Inc. announced that it is moving forward with an operational and financial restructuring to further advance its ongoing strategic transformation and position the Company for long-term success.

  August 9, 2023

   · 

  7 min read
• Business

  Harrow Announces Second Quarter 2023 Financial Results

  Harrow, a leading U.S. eyecare pharmaceutical company, announced results for the second quarter and six months ended June 30, 2023.

  August 9, 2023

   · 

  14 min read
• Business

  PaxMedica, Inc. Announces Second Quarter 2023 Financial Results and Business Update

  PaxMedica, Inc., a clinical stage biopharmaceutical company focusing on the development of novel anti-purinergic drug therapies for the treatment of disorders with intractable neurologic symptoms, provided a business update and reported financial results for the second quarter 2023, ended June 30, 2023.

  August 9, 2023

   · 

  6 min read
• Business

  Context Therapeutics Reports Second Quarter 2023 Operating and Financial Results

  Context Therapeutics Inc., a biopharmaceutical company advancing medicines for solid tumors, announced its financial results for the second quarter ended June 30, 2023, and reported on recent and upcoming business highlights.

  August 9, 2023

   · 

  6 min read
• Business

  Scholar Rock Reports Second Quarter 2023 Financial Results and Highlights Business Progress

  Scholar Rock reported financial results and corporate updates for the second quarter ended June 30, 2023.

  August 9, 2023

   · 

  10 min read
• Business

  Repare Therapeutics Provides Business Update and Reports Second Quarter 2023 Financial Results

  Repare Therapeutics Inc., a leading clinical-stage precision oncology company, reported financial results for the second quarter ended June 30, 2023.

  August 9, 2023

   · 

  16 min read
• Business

  Edesa Biotech Reports Fiscal Third Quarter 2023 Results

  Edesa Biotech, Inc., a clinical-stage biopharmaceutical company focused on inflammatory and immune-related diseases, reported financial results for the three and nine months ended June 30, 2023 and provided an update on its business.

  August 9, 2023

   · 

  11 min read